H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on BiomX (PHGE - Research Report) today and set a price target of $10.00. The company's shares opened today at $0.84.According to TipRanks, Pantginis is an analyst with an average return of -22.6% and a 28.01% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Astria Therapeutics, PDS Biotechnology, and Celldex.BiomX has an analyst consensus of Strong Buy, with a price target consensus of $7.33.See today’s best-performing stocks on TipRanks >>Based on BiomX's latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $8.17 million.
https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-biomx-phge?utm_source=advfn.com&utm_medium=referral
BiomX (AMEX:PHGE)
Graphique Historique de l'Action
De Déc 2022 à Jan 2023 Plus de graphiques de la Bourse BiomX
BiomX (AMEX:PHGE)
Graphique Historique de l'Action
De Jan 2022 à Jan 2023 Plus de graphiques de la Bourse BiomX